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ABSTRACT 
Resistance to bacterial pneumonia may be impaired by 
a pre-existing virus infection. It has been proposed that 
this is due to an effect the virus has on the phagocytic 
and cytopeptic capacities of the alveolar macrophages. 
Guinea pigs were exposed to influenza Al virus in a 
Tri-R ~~orne infection chamber. The alveolar and peritoneal 
macrophages were harvested and allowed to attach to the flat 
surfact of Leighton tubes. These macrophages were then 
challenged with a suspension of Klebsiella pneumoniae for 
2 hours. The macrophages were washed free of extracellular 
bacteria and antibiotics were added to prevent extracellular 
multiplication. Plate counts were made at various time 
intervals on disrupted macrophages to determine the number 
of viable intracellular bacteria remaining. The samples 
counted immediately after the 2 hour challenge were con-
sidered to represent phagocytosis and those counted at 
various times following removal of extracellular bacteria 
were considered to be indicators of either cytopepsis or 
intracellular multipl ication. 
~ vivo virus exposed macrophages ingested the bacteria 
at a rate significantly greater (p<.OS) than that of non-
virus exposed, control macrophages. However, virus exposed 
xi 
macrophages exhibited significantly reduced cytopepsis 
(p <.01) as compared to controls. These effects were 
observed in both the alveolar and peritoneal macrophages. 
It seems that virus infection may reduce host resistance 
to pulmonary bacterial infection by interfering with 
intracellular digestion of the ingested bacteria. 
When the experiment was performed with in vitro 
virus exposure (virus added to attached macrophages in 
Leighton tubes), there was no significant difference in the 
rate of phagocytosis or cytopepsis in either the alveolar 
or peritoneal macrophages. This suggests that the macro-
phages of the virus exposed animals may be different 
populations than those of normal animals or that other host 
factors may be required to react with the cells to lessen 
their effectiveness. 
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SUPPRESSION OF PULMONARY ANTIBACTERIAL ACTIVITY 
BY VIRUS INFECTION 
INTRODUCTION 
Bacterial pneumonia is often preceded by a predisposing 
infection with influenza or other virus. As a result of 
the role that virus plays in the pathogenesis of bacterial 
pneumonia, numerous attempts have been made to classify 
the process involved. However, adequate explanations are 
still not available. Another factor which increases 
interest in the role of viruses in the development of 
disease is the possibil ity that they may also be involved 
as predisposing agents in such chronic diseases as emphysema 
and tuberculosis. 
The purpose of this research is to study the effect 
of viral infection on the phagocytic and cytopeptic 
capacities of alveolar and peritoneal macrophages. The 
macrophage was chosen as the prime subject for investi-
gation because it has previously been impl icated as the 
most important factor involved in pulmonary clearance 
and kill ing of bacteria (25). 
Many workers have studied the reduction of viable 
bacteria in the lung and have used the terms IIclearanceu 
or Ilel imination. 1I Others have used the same terms when 
referring to the mechanical removal of bacteria which may 
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or may not be viable. This use of double meanings for the 
same terms can cause confusion. In this paper the terms 
clearance, cleansing, or el imination are used when referring 
to the mechanical removal of bacteri~ and processes which 
result in the reduction of viable bacteria are referred to 
as bactericidal mechanisms. 
Confusion can arise from different meanings given to 
the term IIphagocytosis. 1I Frequently no distinction is made 
between ingestion and digestion or the two processes are 
treated as one. In this paper the term phagocytosis refers 
only to ingestion; the term cytopepsis is used in reference 
to intracellular digestion. 
REVIEW OF LITERATURE 
Under normal conditions and when mice are exposed 
experimentally to aerosol ized bacteria or are inoculated 
intranasally with bacteria, a portion of the organisms is 
deposited in the lungs (63). These organisms are rapidly 
ingested by alveolar phagocytes, without an inflammatory 
response, and are transported in the mucus I ining of the 
bronchial tree to the esophagus where they are either expec-
torated or swallowed. This phagocytic activity of the alveo-
lar macrophages coupled with humoral, secretory, and cellular 
immune mechanisms provides the primary antimicrobial activity 
of the lungs (25). Also, the stickiness or the adhesive 
property of the mucus is active in trapping foreign sub. 
stances that impinge on the surface of the rrucous. blanket, 
and the particles are moved by the rhythmic waving of the 
cil ia in the epithel ial I ining of the bronchial system (15). 
In the normal lung, large numbers of these organisms 
can be el iminated by various lung clearance and bactericidal 
mechanisms (40); however, if the lung has previously been 
infected with influenza virus, mumps, or reovirus, the 
bacteria persist in the lung and can cause considerable 
damage (33). Following a respiratory infection by virus, 
lung tissue is frequently infected by bacteria that are 
part of the normal flora of the upper respiratory tract and 
4 
are not ordinarily pathogenic. The potentially pathogenic 
organisms in the nose and throat require viral interference 
with pulmonary cleansing function (either clearance or 
kill ing or both) to provide the appropriate setting for 
their estab1 ishment in the lungs. These observations have 
been made in guinea pigs, rabbits, mice, and man. 
In 1923, Stillman (63) reported that when mice were 
exposed to aerosol ized bacteria, the bacteria readily 
penetrated into the lower respiratory tract. Pneumococci 
which were deposited by this method usually disappeared 
within a few hours and gave rise to no infection~ Hemolytic 
streptococci on the other hand persisted in the lung for a 
considerably longer time and a general septicemia usually 
followed. Predictably, this work showed that different 
species of inhaled bacteria have varying degrees of resistance 
to the antimicrobial activities of the lung. 
Shope isolated Haemophi1us inf1uenz~suis from swine in 
1931 and reported that the organism was not pathogenic 
unless there had been prior exposure to swine influenza 
(43). Later (in 1936), he suggested that the virus created 
a portal of entry for the bacteria and converted pulmonary 
tissues to a favorable culture media (61). 
McCordock and Muckenfuss (47) in 1933, before the 
discovery of the human influenza virus, studied rabbits 
with induced pulmonary infections due to the combined action 
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of vaccinia virus and bacteria. They concluded that 
epidemic influenza and interstitial bronchopneumonia in man 
and viral pneumonia in animals were simi1ar, and that 
bacteria could spread more rapidly throughout a lung that 
already had a well developed virus pneumonia than they could 
through a normal lung. They attributed this difference to 
dilatation of the lymphatics in virus infected animals. 
Francis and Torregrose (20) later proposed that 
simultaneous infection with Haemophilus influenzae and 
influenza virus seemed to enhance the virulence of the 
bacteria. They suggested that the viral lesion had some-
thing to do with this effect. 
In 1947, Car1isle and Hudson (4, 5) studied the effect 
of influenza virus on the susceptibil ity of white mice to 
Streptococcus hemolyticus (Group C) administered by intra. 
nasal instillation. They found that susceptabi1 ity to the 
bacteria was greatest betwer :ourth and eighth day 
after viral exposure, but that the resistance was a1so 
significantly lowered on the second and twelfth days. 
Heat-killed virus produced no suppression. 
Volkert, Pierce, Horsfall, and Dubos (69) demonstrated 
that intraperitoneal inoculation of tuberc1e bacill i into 
mice resulted in more severe tl'~ . ~ulosis lesions if the 
mice had a preceding or concomitant infection with 
influenza or pneumonia virus of mice. Furthermore, small 
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doses of these viruses resulted in such a mild infection 
that viral lesions were minimal or absent, yet potentiation 
of pulmonary tuberculous infection still occurred. They 
suggested that the viruses act by some means to make con-
ditions favorable for bacterial growth and for the 
development of tuberculous lesions. 
Harford, Leidler, and Hara (33) reported in 1949 that 
resistance of mice to inhaled pneumococci was lowered to 
the greatest extent two days after the administration of 
influenza virus. Pneumococci disappeared rapidly from the 
normal lung after inhalation but increased in the lung with 
a 5 day viral l:esion. This was explained by the fact that 
gross and microscopic lesions took two days to develop and 
are well developed at 5 to 7 days. The fact that severe 
viral infections due to large inocula or to particularly 
virulent strains caused a greater susceptibil ity to secondary 
bacterial infection seemed to substantiate this explanation. 
They admitted difficulty in reconcil ing the findings of 
Volkert, Pierce, Horsfall, and Dubos (69) of potentiation 
of pulmonary tuberculosis in mice by viral infection so 
mild as to produce few or no lesions. 
In 1950, Merchant and Morgan (48) demonstrated that 
in vivo challenge with either mumps virus or influenza A 
virus (PR8) reduced the ~ vitro phagocytosis of bacteria 
by the polymorphonuclear leukocytes of the guinea pig by 
7 
20 to 30 per cent. 
Harford and Haml in (32) reported in 1952: IIWhen 
severe infection with influenza virus was induced in mice, 
it was found that active cil iary beat persisted in the 
bronchi of involved lungs and that cil ia could be shown 
to be present in stained sections of the viral lesion. 
These findings were unexpected because it was thought that 
t his vir ali n f e c t ion ca use s des t r u c t ion of b ron chi a 1 
epithel ial cells. These results have shown persistence of 
the c i 1 i a ins pit e 0 f s eve rev ira lin f e c t ion and i n d i ca t e 
that the lowered resistance to secondary pneumococcal 
infection which occurs in influenzal pneumonia of the mouse 
is not due to interference with the cil iary mechanism. By 
a process of exclusion, the findings give further support 
to the theory that lowered resistance to pneumococcal 
infection in influenzal pneumonia is due to edema fluid in 
the viral lesion furnishing a culture medium for inhaled 
pneumococci. II Gerone, Ward, and Chappell (22) in 1957 
confirmed the work of Harford et~. (32,33) and 1 ikewise 
concluded that the lowered resistance was due to the viral 
1 es ion. 
Janssen, Chappell, and Gerone (37) reported on the 
synergistic activity between influenza virus and 
Staphylococcus aureus in guinea pigs. Increased mortality 
was observed in animal s receivi ng an aerosol of both vi:rus 
and bacteria. Synergism was observed only in animals 
exposed to staphylococci within 24 hours after exposure 
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to influenza virus but did not occur if the virus fol lowed 
the bacteria. 
In 1956, Ginsberg and his associates (18, 19, 23) 
reported that influenza virus inhibited both phagocytosis 
and anaerobic glycolysis in guinea pig polymorphonuclear 
leukocytes when the virus particles were adsorbed to the 
white blood cell. Phagocytosis was inhibited due to inter-
ference with anaerobic glycolysis at the phosphohexose 
isomerase level of the glycolytic sequence. Boand, Kempf, 
and Hanson (2) observed that influenza virus was adsorbed 
to the surface of leukocytes and that penetration into the 
cell occurred under conditions which satisfy criteria 
for phagocytosis. They also observed that the virus was 
adsorbed to both lymphocytes and neutrophi1s and that 
the phagocytic process was enhanced by the immune state (31). 
In 1962, Ing10t and Davenport (36) confirmed the work of 
Boand, Kempf, and Hanson (2, 31). They observed that 
leukocytes can and do phagocytize influenza viruses, ~ 
vitro and in vivo. They also observed that treatment of 
leukocytes with mumps, influenza, bacterial, and Coxsackie 
viruses inhibited phagocytosis of bacteria and caused shrink-
age of the leukocyte. Even though all of these papers 
reported that viral challenge resulted in changes in the 
9 
phagocytic cells, it was not clear which stage of the 
process was affected because no effort was made to 
differentiate between phagocytosis and cytopepsis. 
Sellers et a1. (59) in 1961 showed that influenza 
virus infection had no significant influence on the popu-
lations of staphylococci in the lungs of mice when the 
bacteria were introduced by the intravenous route. They 
interpreted this as evidence against the induction of a 
general (extrapulmonary)depression of host resistance 
to staphylococci by influenza virus infection. They also 
thought that the existence of persistent but stable 
populations of staphylococci in the lungs of animals infected 
with influenza virus could be a consequence of a diminished 
abil ity of epithelium to destroy or to "wash out" the 
bacteria with bronchiolar secretions, or alternately could 
represent an arithmetic balance of bacterial mu1tip1 ication 
and destruction in the damaged tissues. 
It has been noted that infection with viruses 
initially depresses antibody synthesis. Both IgM and IgG 
production are affected. This depression is most pro-
nounced during the period between the first and fourth 
days after infection but is detectable from the time of 
inoculation until the seventh day (56). Good et a1. 
(14, 52) found that mice of a low-leukemic strain injected 
with Passage A virus and tested before the leukemia 
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appeared formed less antibody against T2 phage than controls 
and were unable to reject allogenic skin grafts with a non-
H2 histocompatibil ity difference. Inhibition of antibody 
formation seemed to be due to a toxic effect on the 
macrophage produced by antigen-antibody reactions. The 
suppression did not occur in the presence of either viable 
antigen or antibody alone, but occurred at the time when 
virus titers fe 11 and ant i body titers rose· (25) . However, 
the effect might be explained in terms of the reaction 
that occurs when macrophages possessing acqul red character-
istics that are referable to cellular immunity are re-
exposed to antigen. In these circumstances, ce11 mobi1 ity 
is. inhibited, and a burst of DNA synthesis occurs. The 
duration of the effect is approximately 48 hours, approxi-
mately the time period during which pulmonary antibacteria1 
activity is suppressed (25). 
In 1964, Laurenzi, Berman, First, and Kass (40) 
thought that because of the small size of the droplet nuclei 
which transported inhaled bacteria, a large share of the 
bacteria were deposited distal to the bronchial tree. This 
suggested the possibi1 ity that the antibacterial mechanisms 
which are presumably responsible for clearance and kill ing 
of the bacteria involve alveolar cells. Green and Kass (27) 
using radiotracer labeled bacteria showed that al though the 
mucocil iary stream is frequently credited with pulmonary 
1 1 
cleansing (el imination and kill ing), both the rate at 
which inhaled viable bacteria are cleared and the rapid 
death of the organisms suggested a mechanism other than 
mechanical removal. They suggested further that bacteri-
cidal mechanisms depended upon the phagocytic activity 
of pulmonary macrophages and that the inhibiting effect 
of chemical, hormonal, and environmental agents could 
be attributed to impairment of the bactericida1 action 
of macrophages by inhibition of either phagocytosis or 
cytopepsis. 
Because phagocytosis by alveolar macrophages is 
inhibited as a result of kidney disease, Kass, Green, 
and Goldstein (38) bel ieved that this inhibition was 
due to the physiological effect of acidosis upon the 
exceedingly sensitive enzyme systems that are critical 
to phagocytosis and cytopepsis. Trey suggested that a 
search be made to identify these enzyme systems. 
Montogomery et ~. (49) in 1967 reported that 
exposure of lymphocytes to phytohemagglutinin in vitro 
provoked the synthesis of protein, RNA, and DNA, and 
stimulated mitosis. Infection of lymphocytes with 
Newcastle disease virus, rubella virus or some other 
viruses interferred with lymphocyte capacity to respond 
to phytohemagglutinin. This association of 1ymphocytes 
with virus inhibited the cell and contributed to per-
1 2 
sistent carrying of the virus. In 1968, Dent and his 
associates (13) also reported that " rubella-vic rus 
infection of human lymphocytes results in inabil ;ty of 
these cells to undergo the metabol ic changes requisite 
to their recruitment for immunological function." 
Salaman (56) reported that the peripheral lympho-
cytes of patients with congenital rubella fail to respond 
to phytohemagglutinin ~ vitro and that normal lympho-
cytes treated in vitro with rubella virus or Newcastle 
disease virus also do not respond. He further reported 
that when certain viruses were injected into adult mice 
before a primary injection of antigen, the resulting 
antibody titers were significantly depressed. This 
depression was definite if the virus was injected from 
one to four days prior to antigenic challenge, but was 
not significant if injected later. 
In 1968, Lepow et~. (42) found that patients who 
had evidence of viral infection yielded Haemophilus 
influenzae in sputum more often than those without this 
evidence. They concluded that perhaps the reason 
patients seldom contract pneumonia without the presence 
of other underlying disease is because it ;s necessary 
to have mUltiple simultaneous infections to produce 
sufficient interference with pulmonary antimicrobial 
funct·j on. 
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Several investigators have reported that certain 
biochemical changes accompany phagocytosis. For poly-
morphonuclear leukocytes these changes include increased 
glycolysis, depletion of glycogen, increased turnover 
of certain lipids, and a marked increase in oxygen 
consumption by way of the hexose monophosphate shunt. 
However, recent work by Bodel and Malawista (3) has 
shown that human leukocytes continue to engage in active 
phagocytosis even during suppression of glycolysis. They 
suggest that some preformed energy source may be available 
to these cells for this function. Changes in ATP leve1s 
were studied, but the results were inconclusive. 
Work done by Sawyer (57, 58) did not confirm the 
earl ier work of Fisher and Ginsberg (19) which 1 inked 
the inhibition of phagocytosis by guinea pig polymorpho-
nuclear leukocytes to the virus-induced reduction in 
glycolysis and suggested that the virus inhibited 
g1ycolysis by interfering with the enzyme phosphohexose 
isomerase. Sawyer found that inhibition of glycolysis 
and inhibition of phagocytosis due to influenza viruses 
were poor1y correlated among different cell types 
(exudate PMN and macrophages and alveo1ar macrophages) 
and species. Although the correlation between inhbition 
of glycolysis and inhibition of phagocytosis was imperfect, 
he thought that a causal relationship could not be 
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exc1uded. His resu1ts also indicated that attachment 
of virus, action of viral neuraminidase, and ingestion 
of virus did not alone account for the inhibition of 
phagocytosis. Green and Kass (28) suggested that 
alveolar macrophages depend on oxidative metabol ism 
for the energy for phagocytic activity and are unsuited 
metabol ically to carry out this function under conditions 
of reduced oxygen tension. 
Sawyer (57) visual ized the interaction of influenza 
virus with leukocytes as a complex process involving at 
least four separate reactions: "First, the virus attaches 
to receptors on the cell surface by a process that is 
both relatively insensitive to temperature and inde-
pendent of energy production by the cell. After 
attachment, two reactions compete: the action of viral 
.neuraQl in i, dase on the recep tors to cause e 1 uti on of the 
virus, and the ingestion of attached virus by the 
leukocytes. The first of these reactions is dependent 
on temperature; the enzyme is essentially inactive at 
40 C and maximally active at 37 0 C. The second of the 
competing reactions, ingestion of virus, depends on 
glycolysis and is inhibited by both low temperature 
and enzyme inhibitors such as sodium fluoride. Finally, 
intraleukocytic virus is apparently destroyed by an 
unknown mechan i sm. II 
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In 1969, Kl ine and Green (24, 39) studied the effects 
of reovirus infection on the e1 imination of viable bacteria 
from the lungs of mice. Although inoculation of reovirus 
intranasal ly caused only minimal pulmonary pathology in 
the mouse when contrasted with the marked changes pro-
duced by influenza viruses, the suppression of the 
pulmonary pathology in the mouse when contrasted with the 
marked changes produced by influenza viruses, the suppres-
sion of the pulmonary antibacterial capacity that it 
produced was similar. None of the mice showed necrosis 
of tissue, exudation of edema fluid into alveol i, or 
evidence of damage to cil iated cells of the bronchial 
tree. The titers of virus in the lungs were highest 
on days 3 and 7, and decl ined on day 10, and were still 
lower on day 14 after intranasal inoculation. Specific 
neutral izing antibody could be detected in serum as early 
as day 14 after i nocul at ion. "Reov i rus infect ion 
significantly decreased the antibacterial activity of the 
murine lung. This impairment could be demonstrated only 
during the 1 imited periods which included test days 7 and 
10 but not 3 or 14. The reovirus effect was dose-dependent 
and did not occur with small inocula of virus. 1I They 
thought that this effect might be produced by the action 
of the viral infection on the alveolar macrophage. 
Degre'and Glasgow (12) used parainfluenza 1 virus to 
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reduce the resistance of mice to Hemophilus influenzreB. 
Their data estab1 ished the occurrence of a synergistic 
effect in mice as evidenced by the increased incidence of 
of pneumonia and the decreased capacity of virus-infected 
mice to clear bacteria from the lung. The effect was 
f 0 un d to beg r ea t est w hen the b act e ria 1 i n f e c t ion 
o ccu r red 4 da y s aft e r vir ali n oc u 1 a t ion. The mo r tal i t Y 
rate was dependent on the dose of both agents; a high 
mortal ity resulted from an increased inoculation of either 
virus or bacteria. Inactivation of either agent resulted 
in mortal ity that was not significantly different from the 
effect of a single agent. The same effect was observed 
when the mice had been previously immunized with either 
agent. The lungs of mice infected with parainfluenza 
virus were found to show increased hyperemia and peri-
bronchial cell infiltration, with both mononuclear and 
polymorphonuclear cells. Animals infected with para-
influenza 1 virus showed a normal capacity to kill 
bacteria in their lungs during the first 2 hours following 
infection. It was concluded that enhanced susceptibility 
was not expl icable by impaired phagocytosis during the 
initial phase of infection. El imination of the remaining 
bacteria or prevention of bacterial rep1 ication was 
delayed in the virus-infected mice. The investigators 
were unable to determine if this effect on late clearance 
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was due to the action of the virus on phagocytosis or 
other factors involved in host resistance. Their data 
suggested that bacterial mUltipl ication made a significant 
contribution to the infectious process and that although 
there was no correlation between virus repl ication and 
production of disease, the establ ishment of infection with 
active parainfluenza virus was necessary for the occurrence 
of the observed synergism. 
It has been shown that the viral enzyme, neuraminidase, 
hydrolyzes the polysaccharides of the mucoproteins of the 
mucous 1 inings to render them ineffective as bacterial 
inhibitors; fur.ther, that the influenza virus-polymorpho-
nuclear leukocyte reaction elaborates an endogenous pyrogen 
which inhibits phagocytosis by interfering with anaerobic 
glycolysis of leukocytes (11). 
The importance of interferon production by the 
alveolar macrophage system in response to virus infection 
in vitro stems from the possibil ity that the process of 
interferon production competes with macrophage activity 
in phagocytosis. An argument against this explanation is 
that alveolar macrophage activity has been reported to be 
normal in the first four days of influenza infection when 
interferon titers are,at a peak level; but when interferon 
titers are virtually gone (seventh to tenth day), inhibition 
of alveolar macrophage activity is seen (25). Other 
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investigators reported maximum inhibition of macrophage 
activity four days after infection. 
Rylander (53) reported that II ••• if mucUS present in 
excess in the upper part of the airways is drained into 
the alveol i and taken up by the phagocytes, their capacity 
to inactivate bacteria then becomes reduced. Recent data 
indicates that this is due to a toxic effect of certain 
saccha rides in the murus on the phagocyt i c ce 11 s. II 
Green (25) suggests that the hypotheses to explain 
the suppression of pulmonary antibacterial activity by 
virus infection can be divided into those which interfere 
with the physical removal of the bacteria from the lung 
and those which interfere with kill ing or inactivation 
of the bacteria. Physical removal involves such processes 
as cough, expectoration, mucus flow from the alv,eol i to 
the ph a r y nx prop ell ed by c i 1 i a, 1 y mp hat i c flow from the 
lungs to the regional lymph nodes, and blood flow. The 
kill ing and inactivating processes can be subdivided into 
the cellular processes involving inflammatory cells such 
as alveolar macrophages, polymorphonuclear leukocytes, and 
monocytes, as well as the nonphagocytic lymphocytes, 
plasma cells, eosinophils and epithel ioid cells of granulo-
matous reactions; and the humoral processes involving 
various types of antibodies (lgG, IgM, and secretory IgA), 
plus nonantibody substances such as complement, lytic 
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enzymes, interferon, and probably as yet unknown factors. 
Green has recently summarized the problem as follows: 
liThe pathogenesis of many chronic nonspecific pulmonary 
granulomatous, fibrotic, emphysematous, asthmatic, bron-
chitic, and inflammatory diseases involves a mUltipl icity 
of genetic, infective, allergenic, chemical, physical, 
and other endogenous and environmental factors. A unifying 
concept of pathogenic mechanisms in these disorders must 
account for the involvement of different combinations of 
these etiologic factors and the variation of expression 
among different individuals of certain combinations of 
these factors. II 
As a result of the knowledge that has been gained 
in studying the viral suppression of pulmonary anti-
bacterial activity, it is logical to assign this unifying 
role to the alveolar macrophage. This cell is closely 
related to immunological and biochemical reactions and 
interference with its function allows relatively innocuous 
organisms to assume the role of pathogens. 
It may be concluded that the 1 iterature supports the 
concept that viral infection provides a synergistic effect 
for bacterial infection. The exact mechanisms of this 
interference with host resistance remains to be clarified. 
It is apparent from this review of the 1 iterature 
that I ittle is known of the effects of virus infection 
upon the phagocytic and cytopeptic activities of the 
a 1 veo 1 a r ma crop hag e . I tis prop os e din t his stu d Y to 
correlate ingestion and digestion rates of alveolar 
macrophages following in vitro and in vivo exposure to 
i n flu e n za vir us. 
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MATERIALS AND METHODS 
I. EXPERIMENTAL ANIMALS 
Albino guinea pigs (Cavia cobaya) of the Hartley 
strain were used. They were all males obtained from a 
local source and were fed commercial pellets, water and 
fresh lettuce. 
I I. MICROORGANISMS 
The bacteria used as indicators of phagocytosis and 
cytopepsis in this study were Klebsiella pneumoniae strain 
U-119 provided by Dr. Stanley Marcus from the University 
of Utah bacterial culture collection. They were maintained 
on nutrient agar slants at room temperature and were trans-
ferred every 7 to 10 days. 
The virus used to infect the phagocytes was influenza 
Al/Ann Arbor/l/S7 seed virus (ATCC Cat. #VR-479) whi'ch was 
propagated in chick embryo and stored at -70 C. 
I II. TISSUE CULTURE MEDIA 
All phagocytes were harvested and maintained in the 
following media which was prepared as 10 X and diluted to 
1 X as needed: 
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Earle's Balanced Salt Solution (BSS) 10 X 
Phenol Red 0.2 9 
Sodium Chloride (Na C 1 ) 68.0 9 
Potassium C h lor i de (KC 1 ) 4.0 9 
Magnesium Sulfate (MgS0497H2O) 2.0 9 
Sodium Phsophate Monobasic (NaH2P02·H2O) 1 . 4 9 
Glucose ( Dextrose) 10.0 9 
Calcium Chloride (CaC1 2) 2.0 g 
Distilled Water ( H2O) to 1000 ml 
The calcium chloride was dissolved separately in 100 
m1 of distil led water and added to the other reagents 
just before the solution was brought to 1000 m1 total volume 
with distilled water. 
The stock (10 X) solution was diluted 1 :10 for use 
and the final pH was adjusted to 7.4 with saturated 
sodium bicarbonate (NaHC03). 
To the above solution the following constituents were 
added as required by experimental design: 
Fetal Calf Serum (Hyland) 20% 
(final concentration by volume) 
Penici 11 in G (Squibb) 
Dihydrostreptomycin (Squibb) 




Antibiotics were added to the media used to harvest 
the phagocytes and to the med i a used to .. ma i nta i n the 
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phagocytes after exposure to the bacteria. 
IV. PROPAGATION OF VIRUS 
A. Allantoic Cavity Inoculations 
Fertile eggs were incubated in an upright position 
(large end up) for 10 to 14 days at 99 t F and 85-86% 
relative humidity in a Humidaire Model 50 incubator. The 
eggs were then candled and the air spaces and embryos 
marked. The egg was wiped with 70% alcohol and a hole 
was punched in the shell over the air sac with a cut-off 
hypodermic needle fitted to a syringe barrel with a rubber 
stripper to restrict depth of penetration. The egg was then 
set on the candler and through the hole was inserted the 
shaft of a 1t inch 24 or 26 gauge needle attached to a 
1 m1 syringe containing the inoculum, which consisted of 
influenza A1/Ann Arbor/1/S7 seed virus (ATCC Cat. #VR-
479) diluted 1 :100 in nutrient broth. The embryo was 
located by observing the position of the eye, which was 
opaque when the egg was transi11uminated. A quick stabbing 
motion was made with the syringe, as if to transfix the eye. 
When the amniotic sac had been entered the dark shadow 
of the eye was seen to move when the tip of the needle was 
moved. A volume of 002 ml of inoculum was then injected. 
The hole was sealed with fingernail pol ish or cellophane 
tape and the eggs were incubated in a upright position for 
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24 to 72 hours at 37 c. 
B. Harvesting the Amniotic and Allantoic Fluid 
Prior to harvesting the eggs were chilled for several 
hours to minimize hemorrhaging. The upper half of the 
shell was cleansed with either 70% alcohol, tincture of 
iodine or merthio1ate. The shell was removed by cutting 
with scissors around the margin of the allantoic membrane 
which had been previously marked. The exposed opaque 
shell .membrane and the transparent allantoic membrane 
were then cut away and the torn edges were laid over the 
shell. The allantoic fluid was decanted or removed with 
a syringe. The forceps and the tip of the needle were 
manipulated in such a way as to prevent the amnion and 
other surrounding membranes from interfering with the 
removal of the fluid. 
The amniotic fluid was also removed with a needle 
and syringe. The amnion was picked up with fo~ceps 
held in the left hand ahd the fluid was removed with a 
5 ml syringe and 18 gauge needle or capillary pipette 
held in the right hand. If the yield of fluid was small, 
the sac was flushed with 1.0 ml of buffered sal ine solution. 
The allantoic fluid and amniotic fluid from individual 
eggs were placed in separate sterile test tubes (4l)~ 
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V. VIRUS TITRATION 
A. Virus Titration by Microtechnique (Hemagglutination) 
A 1 :10 dilution of the harvested allantoic and amniotic 
fluid was made by adding 1.8 ml of sterile sal ine to 0.2 
ml of fluid containing the virus. One microtiter loop 
(0.025 ml) of this fluid was then serially diluted in 
0.025 ml of sterile sal ine in the wells of a microtiter 
plate. To each well was added 0.050 ml of either 0.25% 
chicken red blood cell suspension or 0.50% guinea pig 
red blood cell suspension. eel ls were allowed to sediment 
for 24 hours before reading. The end point of the titra-
tion was the last dilution showing complete agglutination. 
Unagglutinated dilutions appeared as dots which could be 
accentuated by tipping the plate and observing the "tear 
drop" pattern. Agglutinated cells remained adherent to 
the p 1 ate (60). 
B. Virus Titration by Tube Method (Hemagglutination) 
One ml of a 1 :10 dilution of virus containing fluid 
was placed in the first of a series of Kahn tubes (13 x 
75 mm). The remaining tubes contained 0.5 ml of sterile 
sal ine. Virus containing fluid (0.5 ml) was then 
serially diluted in these tubes. To each was added 0.5 
m1 of either 0.5% chicken red blood cell suspension or 1% 
guinea pig erythrocyte suspension. The tubes were then 
shaken and al lowed to incubate at room temperature for 
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one hour. They were read by the same method used in the 
microtechnique (41)0 
VI. QUANTiTATiON OF BACTERrAL SUSPENSIONS 
The bacterial content of suspensions was quantitated 
by optical density and plate counts. 
A. Optical Density 
The best wave length to use in measuring the optical 
density of the bacterial suspensions was determined by 
measuring the optical density of Earle's balanced salt 
solution with 20% calf serum. Measurements were made with 
the medium at different pHis, with and without anti-
biotics, and with and without bacteria. The best wave 
length was considered to be that wave length which 
demonstrated the least variation in optical density due 
to pH change or addition of antibiotics. It was also 
desirable that the 1 ight absorption due to the bacteria 
in the suspension be high at this point so that good 
sensitivity could be achieved. A wave length of about 
625 mu met these criteria best. 
The suspension being quantitated was placed in a 
cuvette and the optical density determined by reading at 
625 mu as compared with a blank of fluid similar to that 
in which the organisms were suspended (Earle's BSS). The 
measurements were made on a Coleman Junior Spectrophotometer. 
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B. Plate Counts 
The number of viable Klebsiella pneumoniae in the 
bacterial suspension which had been measured for optical 
density was determined by making plate counts. Serial 
ten fold dilutions of the suspension were made. A clean 
1.0 ml glass pipette was used in each transfer in order 
to el iminate the problem of carry overe 
One ml of solution from each of the dilution tubes 
between 10- 6 and 10- 10 was placed in each of three petri 
dishes. Pour plates were made by adding 1 iquid nutrient 
agar which had been cooled to a temperature that was not 
uncomfortable to the cheek (about 48 C). The plates were 
rotated in a figure-eight pattern to mix the bacteria and 
were then incubated for 48 hours at 37 C. Colony counts 
were made using a Quebec colony counter and hand tally. 
The number of vaible bacteria per given volume of stock 
suspension was calculated taking into consideration the 
volume of inoculum and dilution giving the optimum 
population for counting. Ordinarily only those plates 
giving counts between 30 and 300 colonies were used, 
but when none of the plates fell in this range, the calcu-
lations were made from the plates which fell nearest 
above this range. 
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VI I. ANTIBIOTIC SENSITIVITY OF KLEBSIELLA PNEUMONIAE 
The sensitivity of Klebsiella pneumoniae strain U-119 
to penicill in and dihydrostreptomycin was determined by the 
tube dilution method. The dihydrostreptomycin was prepared 
by diluting the stock solution, which contained 500 mg/m1, 
1 :100 and adding 2.2 m1 of this to 14 m1 of brain heart 
infusion broth. This was serially diluted to give concen-
trations of 80 through 0.16 ug/m1. The penici11 in was 
prepared by diluting the stock solution, which contained 
1,000,000 units/m1, 1 :100 and adding 1.6 m1 of this to 
14 m1 of brain heart infusion broth. This was serially 
diluted to give concentrations of 114 through 0.2 units/ 
m1. One loop of bacteria was inoculated into each tube 
and they were incubated at room temperature for 24 hours. 
The end point was taken as the lowest concentration that 
prevented the development of turbidity after incubation. 
VI I I. RATE OF INACTIVATION OF BACTERIA BY ANTIBIOTICS 
Klebsiella pneumoniae strain U-119 was grown over-
night at room temperature in Earle's BSS. It was adjusted 
to 108 organisms/m1 and antibiotics were added. One 
tenth m1 of 100 X antibiotics were added to 10 ml of 
fluid to give the same antibiotic concentration that is 
used in the ordinary experimental procedures. At various 
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times samples were removed and pour plates were made. 
Plate counts were made two days later. 
IX. PHAGOCYTE HARVESTING TECHNIQUES 
A. Peritoneal Exudate Cells 
Peritoneal exudates were stimulated in guinea pigs 
by intraperitoneal injection of 10 m1 of glycogen (0.2 
mg/10 m1). Three days later the guinea pigs were sacri-
ficed by electrocution and the peritoneal exudate harvested. 
The guinea pigs were attached dorsal side down to an 
animal board. The hair over the peritoneum was wetted 
with 70% ethyl alcohol. The peritoneal cavity was 
opened and 50 ml of E2rle ' s BSS containing 20% calf serum 
and antibiotics were added. This fluid was removed by 
aspiration using a syringe fitted with an aspirating 
needle and rinsed in a heparin solution. The process was 
repeated until a total volume of 50 ml of exudate was 
recovered. The phagocyte containing exudate was then 
centrifuged at BOO-1000 rev/min. for 10 minutes in 
sfl iconized (SC-B7 Ori-Film, General Electric) 50 ml 
centrifuge tubes. The supernatant fluid was discarded 
and the sedimented cells resuspended in Earle's BSS with 
antibiotics. 
B. Alveolar Phagocytes 
Guinea pig alveolar phagocytes were harvested by the 
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method of Maxwell, Dietz and Marcus (46). An adult guinea 
pig was sacrificed by electrocution. The guinea pig was 
positioned on an animal board in such a manner that the 
trachea could be easily exposed. The upper part of the 
trachea was carefully dissected free and a hemostat 
fastened to its wall. The trachea was then transected 
above this point and was cannulated with the tip of a 
three-way stopcock (modified by grinding down the tip to 
an approximately 1/16 inch outside diameter; Leur Lok, 
Leur Lok, Leur Sl ip). Two 50 m1 Leur Lok syringes were 
then attached to the stopcock and supported by a ring 
stand and clamp. The upper (reservoir) syringe was filled 
with Earle1s balanced salt solution. After adjusting the 
stopcock valve, 15 m1 of fluid were carefully injected 
tnto the lungs. Care was taken to avoid overinflation 
and hemorrhage. The stopcock valve was then adjusted to 
allow the cell suspension to enter the receiving syringe. 
Very 1 ittle pressure was needed to draw 5 to 10 ml of 
fluid from the lungs. This procedure was continued until 
a total of 50 m1 of macrophage containing fluid was 
obtained. The macrophage suspension was placed in sil icon-
ized 50 ml centrifuge tubes and centrifuged at 800-1000 
rev/min for 10 minutes. The supernatant fluid was 
discarded and the cell buttons were resuspended in Earle1s 
BSS. 
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x. CELL COUNTS 
Tota 1 , differential and viable ce 11 counts were made 
on both the alveolar and per i tonea 1 ce 11 s. 
A. Total Cell Count 
A samp 1 e of the ce 11 suspension was diluted in a 
leukocyte pipette and the cells were counted using a 
hemocytometer ( 21 ) . 
8. Differential Cell Count 
Smears were made by spreading the cells on glass 
sl ides, using a disposable capillary pipette. The smears 
were air dried, heat fixed, stained for 1 minute with 
Wright's stain, buffered for 4 minutes with Wright's 
buffer, washed and air drfed .. The percentage of mono-
cytes, lymphocytes and polymorphonuclear leukocytes was 
then determined (21). 
C. Viable Cell Count 
The viabil ity was determined by the eosin dye exclusion 
technique of Hanks (30). One drop of the cell suspension 
was mixed with one drop of 1% eosin Y dye solution on a 
microscope sl ide. Under the microscope the viable cells 
appeared plump, smooth and only sl ightly stained by the 
dye. The nonviable cells were flattened, rough and were 
heavily stained by the eosin dye. 
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XI. RESISTANCE OF KLEBSIELLA PNEUMONIAE TO DISRUPTION 
One half m1 of sterile ga1ss beads was added to 
sterile Leighton tubes. To this was added 2 ml of Earle's 
BSS with 103 Klebsiella pneumoniae/ml (as determined by 
optical density). The tubes were then exposed to ultra-
sound or mixing or both for various times. The media was 
then removed, serially diluted and added to pour plates. 
Tripl icate colony counts were made from these plates. 
XI I. SUSCEPTIBILITY OF MACROPHAGES TO DISRUPTION 
One ml of Earle's BSS containing 106 macrophages was 
added to each Leighton tube and allowed to attach overnight. 
The tubes were observed macroscopically and microscopically 
to determine the approximate extent of macrophage attachment. 
The tubes were then rinsed with fresh media and observed 
again. After various times of exposure to the disruption 
procedures previously described, the approximate numbers 
of viable macrophages attached to the side of the Leighton 
tube was determined. This was done by adding 1% eosin Y 
stain and counting the number of macrophages per microscope 
field which excluded the dye. Smears were made of the 
fluid from the Leighton tubes. These were stained with 
eosin Y stain and examined microscopically for viable 
macrophages. 
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Xl I I. PHAGOCYTOSIS AND CYTOPEPSIS 
A. In Vi tro Vi rus Exposure 
Phagocyte cell suspensions, after counting, were dilu-
ted in Earle's BSS with antibiotics to contain 106 cells/ 
ml. One ml of each suspension was added to (a) Leighton 
tubes with micro coversl ips for microscopic observation 
by means of various stains, and to (b) Leighton tubes 
without coversl ips for gross observation and bacterial 
viabil ity studies. The cells added to the Leighton tubes 
were allowed to attach to the glass overnight and could 
be observed as a cel 1 film macroscopically or as individual 
cells microscopically. 
Virus was diluted 1 :10 in Earle's BSS with anti-
biotics; one ml was placed in each Leighton tube of the 
test group and was allowed to incubate overnight. The 
control group received Earle's BSS with antibiotics only. 
The tissue culture media was then removed and the 
cell monolayer was washed with fresh media (without anti-
biotics). To each tube was added one ml of Earle1s BSS 
without antibiotics which contained 10 6 Klebsiel la/ml. 
Phagocytosis was allowed to occur for 2 hours after which 
the bacteria which remained extracellular were washed off 
the cell monolayer and one ml of Earle's BSS with anti-
biotics was added to the cells. 
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Plate counts of the viable intracellular organisms 
were made at various times after the Klebsiella pneumoniae 
were added to the phagocytes. One half ml of sterile glass 
beads (0. 1 mm in diameter) was added to each tube. The 
Leighton tube was held horizontally and the flat window 
area of the tube was exposed to 30 seconds of ultrasound 
(20,000 cycles/sec, the surface of the tube being allowed 
to rest on the probe of the instrument). When examined 
microscopically, the monolayer was found to be completely 
detached from the glass surface. The contents of each 
tube were mixed thoroughly on a Vortex mixer for 30 seconds. 
Samples were removed, diluted serially throughlO-fold 
dilutions and pour plate counts were made in triplicate 
on these dilutionso 
8. ~ Vivo Virus Exposure 
Guinea pigs were placed in a basket which was put into 
the exposure chamber of a Tri-R airborne infection apparatus. 
The virus suspension was diluted 1 :10 in Earle's 8SS and 
5 ml of this solution were placed in the nebul izer~ 
venturi unit. Control animals were exposed to an aerosol 
of Earle1s 8SS with no virus. The a r pressure and vacuum 
controls were adjusted for proper flow; approximately 
5 1 iters/min for the compressed air and 28 liters/min for 
the chamber flow. The droplets formed dry to droplet-
nuclei before reaching the infection chamber and form an 
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ambient cloud. This cloud was allowed to build up for 
30 minutes, after which thenebul ization was stopped, 
the UV 1 jght was turned on and the cloud was allowed to 
decay for 30 minutes. The size of the droplet nucleus 
has been reported to be about 1 to 2 u which would mean 
that most of the inhaled droplets would be deposited in 
the alveolar spaces. 
Four days after the virus exposure, the macrophages 
were harvested, the cells were suspended in Earle's BSS 
and 1 ml (10 6 cells/ml) was added to each Leighton tube. 
The cells were allowed to attach to the glass overnight, 
then bacterial challenge and plate counts were performed 
as in the in vitro experiments. 
XIV. STATISTICAL ANALYSIS 
Statistical analysis was performed by the University 
of Utah Computer Center. Factorial analysis was done on 
each of the experiments using the MANOVA computer program 
from the Program Library. This program performs uni-
variate or multivariate analysis of variance or co-
variance and regression. The BMD07V computer program 
from the Bio-Medical Library was also used. This 
program computes an analysis of variance table for one 
variable of classification. The treatment group or 
category means are ranked in increasing order and a 
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multiple range test, using significance ranges input by 
the user, is performed on the ranked means. Probabil ity 
levels of .05 and .01 were used. 
A three character abbreviation was used in the 
statistical tables to indicate the different groups. 
The first letter indicates treatment (V = virus exposed, 
C = control, no virus exposure), the second letter 
indicates the location or source of the cells (A = 
alveolar, P = peritoneal), and the third character 
indicates the time the bacteria were exposed to the 
cells (2 = 2 hours, + = >2 hours). 
EXPERIMENTAL RESULTS 
I. VIRUS PROPAGATION 
Influenza virus was grown and harvested according to 
the procedures described in Materials and Methods. The 
first harvest was titrated by the microtechnique of the 
hemagglutination test. The allantoic fluid from each 
egg harvested was kept separate and titrated. The titers 
of harvests which demonstrated hemagglutination are given 
in Table 1. The second harvest fluids were titrated by 
both the microtechnique and by the tube method. The 
titers of allantoic fluids which demonstrated hemaggluti-
nation are given in Table 2. The lower titers in the tube 
test results shown in Table 2 may have been the result 
of storing the virus at -20 C instead of the recommended 
-70 C. Subsequently, all viruses were stored at -70 C. 
I I. QUANTITATION OF BACTERIAL SUSPENSIONS 
The method chosen for quantitation of the bacterial 
content of suspensions of Klebsiella pneumoniae in Earle's 
BSS was the spectrophotometric method. It was chosen 
because it is more rapid, convenient and accurate than 
other methods which could have been used, such as plate 
counts, microscope counts, or packed cell volumes. The 
wave length selected for determining the optical density 
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TABLE 1. Hemagglutination Titers of First Virus Harvest 
Tube Number Guinea Pig Ce 11 s Chicken Cells 
20 320 
3 160 20 
10 320 80 
1 2 320 640 
14 160 320 
16 40 40 
1 7 40 80 
18 0 20 
20 40 0 
26 40 40 
28 40 80 
32 40 0 
33 20 20 
34 20 40 
35 160 320 
37 2560 2560 
40 160 320 
43 20 80 
48 0 2560 
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TABLE 2. Hemagglutination Titers of Second Virus Harvest 
Microtiter Tube Method 
Tube Number Chick Cells G . P. Ce 11 s Chick Cells G.P. Ce 11 s 
2560 1280 320 40 
7 2560 320 0 20 
10 2560 2560 0 20 
19 2560 640 320 40 
20 80 2560 0 40 
23 2560 640 80 40 
24 2560 640 80 20 
25 320 2560 0 40 
28 2560 2560 320 40 
34 2560 1280 320 80 
35 640 1280 320 40 
42 640 640 160 80 
43 640 160 40 
53 160 640 160 40 
54 640 640 160 40 
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was 625 mu. This wave length was selected because at 
that point the smallest amount of variation occurred 
due to pH change or addition of antibiotics, as shown by 
Tables 3 and 4 and Figures 1 and 2. Also, at this point 
the 1 ight absorption due to the bacteria in the suspension 
was high enough to give adequate sensitivity for this 
determi nat ion. 
Plate counts were made of a suspension of Klebsiella 
pneumoniae which had an' optical density of 0.23. The 
results shown in Table 5 indicated that this suspension 
contained 3.43 X 108 organisms/ml. It was found, as 
is shown by the data in Table 6, that the relationship 
between the optical density and the number of organisms 
was 1 inear. Consequently, a curve was plotted, Figure 3, 
to show the number of organisms in relation to the optical 
density of the suspension. 
I I I. ANTIBIOTIC SENSITIVITY OF KLEBSIELLA PNEUMONIAE 
The organism (Klebsiella pneumoniae) to be used as 
indicator of the rate of phagocytosis and cytopepsis was 
tested for antibiotic sensitivity to insure that it was 
sensitive to the antibiotics at the concentrations used 
in these experiments. The tests showed that the organism 
was sensitive to dihydrostreptomycin at a concentration 
of 1.25 ug/ml and sensitive to penicill in at a concentration 
TABLE 3. Effect of pH Change on Optical Density 
of Earle's BSS at Various Wave Lengths 
Wave Length 
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(mu) pH 7.2 pH 7.4 pH 8.2 
400 1 . 70+ 1 .60 1 . 1 5 
425 1 . 70 1 .60 1 .05 
450 1 .40 1 f 40 1 .00 
475 1 . 1 0 1 . 1 0 1 .05 
500 082 .90 1 . 25 
525 .68 .87 1 . 70 
550 .59 .87 1 . 70 
575 .38 .55 1 . 00 
600 . 16 .. 20 .36 
625 . 1 1 • 1 1 . 16 
650 .. 21 .20 .22 
675 .. 31 .30 .32 
700 .37 .36 .38 
TABLE 4. Effect of Antibiotics and Bacteria on 
Optical Density of Earle's BSS* at Various Wave Lengths 
Wave Length (mu) BSS +Antibiotics +Bacteria 
400 1 .60 1 .70+ 1. 70+ 
425 1 .60 1 • 70+ 1 .70+ 
450 1 .40 1.40 1 .50 
475 1 • 1 0 1 .20 1 .30 
500 .90 1 .05 1 • 1 0 
525 .87 1 .05 1 .05 
550 .87 1 .05 1 .05 
575 .55 .65 .70 
600 .. 20 .25 .3 1 
625 .. 1 1 • 1 3 .20 
650 .. 20 .23 .29 
675 .30 .33 .39 
700 .36 .. 38 .43 
* pH = 7.4 
42 
43 
TABLE 5. Plate Count of Suspension of Klebsiella pneumoniae 
D i 1 uti on 1st Plate 2nd Plate 3rd Plate Average 
10- 6 355 362 312 343* 
10- 7 20 23 22 21 . 7 
10. 8 4 2 1 1 5.67 
10-9 0 0 0.33 
10. 10 0 0 0 0 
* 3.43 X 108 org/m1 in Earle's BSS at OD 0,23 
TABLE 6. Optical Density of Suspensions of 
Klebsiella pneumoniae 
Dilution 1st Reading 2nd Reading Average 
Undiluted .23 .23 .23 
1 : 2 . 1 1 Q 1 1 . 1 1 
1 : 4 .06 .06 .06 
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Figure 2. Effect of Addition of Antibiotics and Bacteria on Optical 
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of 1.7 units/ml. This was well below the concentration 
used in these experiments. The concentrations actually 
used were those recommended by the Squibb Company to be 
used to inhibit growth of chance contaminants in tissue 
culture media (62). 
IV. RATE OF INACTIVATION OF BACTERIA BY ANTIBIOTICS 
The results of the rate of inactivation experiment 
are shown in Table 7. The rate of inactivation (k) was 
computed from the formula: 
log n 
I = -kt og no 
where n equals the number of viable organisms at zero 
o 
time and n equals the number of viable organisms after 
time t. 
n = 2.88 X 108 org/ml, 
o 
log 4.00 X 10 7 org/ml 
, . 
log 2.88 X 108 org/m1 
0.899 = -k 2 hr 
n = 4.00 X 
-k . 2 hr or 
k -0.449 
10 7 org/m 1 , t = 
7.60 






The decimal reduction time (0) or the time required 
to reduce the count 10-fold was computed by the relation-
ship: 0 = l/k 
1 o = ______ 't-JiIr"_..._...,...,..--
-0.4491/hr o = -2.225 hr 
These antibiotics reduce the number of viable 
hr 
49 
TABLE 7 . Plate Counts of Klebsiella I2neumoniae for 
Rate of Inactivation by Antibiotics 
Exposure D i 1 ut ion 1st Plate 2nd Plate 3rd Plate Average 
Time 
Control 
10- 2 (No Anti- TNC TNC TNC 
biotics) 10- 4 TNC TNC TNC 
10- 6 278 320 267 288 
o min. 10. 2 TNC TNC TNC 
10-4 TNC TNC TNC 
10-6 257 256 228 247 
15 min. 10- 2 TNC TNC TNC 
10. 4 TNC TNC TNC 
10-6 189 161 142 164 
30 min. 10- 2 TNC TNC TNC 
10- 4 TNC TNC TNC 
10. 6 154 1 3 1 143 
45 min. 10- 2 TNC TNC TNC 
10- 4 TNC TNC TNC 
10-6 96 11 0 78 95 
60 min. 10- 2 TNC TNC TNC 
10- 4 TNC TNC TNC 
10. 6 98 85 100 94 
120 min. 10- 2 TNC TNC TNC 
10- 4 TNC TNC TNC 
10.6 37 52 32 40 
50 
organisms by a factor of 10 every 2.225 hours unde~ the 
experimental conditions used. 
V. RESISTANCE OF KLEBSIELLA PNEUMONIAE TO DISRUPTION 
The effect of the macrophage disruption procedures 
on Klebsiella pneumoniae are shown in Table 8. The number 
of viable organisms did not decrease when they were 
subjected to ultrasound for 5 minutes or mixing for 5 
minutes. They did decrease when subjected to ultra-
sound for 5 minutes followed by mixing for 5 minutes. 
In some of the experiments which follo~ a disruption time 
of 30 seconds was used while in others 1 minute was used. 
VI. PHAGOCYTOSIS AND CYTOPEPSIS 
A. I n V i t r 0 Vir us Ex p 0 sur e 
f.igures 4, 5, and 6 and Tables 9 through 17 show the 
results of three separate experiments in which the macro-
phages were exposed to the virus in vitro. The count 
given for the control sample of the alveolar macro-
phages on the 8 hour time (Table 9) was generated by 
the computer from the formula: 
where Ai= mean of all controls 
"8]= mean of all alveolar macrophages 
'C3= mean of all 8 hour samples 
and ~ = mean of all samples (grand mean). 
TABLE 8. Resistance of Klebsiella pneumoniae 
to Macrophage Disruption Procedures 
Plate Counts (10- 1 d i 1 uti on ) 
Treatment 1st 2nd 3rd 
Plate Plate Plate Average 
None 95 57 57 70 
Sonification 0.5 min. 144 114 120 126 
Sanification min. 152 218 154 175 
Sonification 2 min. 142 1 75 136 1 51 
Sonification 5 min. 212 261 236 236 
Mixing 0.5 min. 164 196 220 193 
Mixing min. 182 168 182 177 
Mixing 2 min. 119 149 142 137 
Mixing 5 min. 148 155 113 139 
Sonification 0.5 min. 
plus Mixing 0.5 min. 131 154 134 140 
Sonification 5 min. 
plus Mixing 5 min. 58 41 33 44 
5 1 
TABLE 9. Plate Counts of Intracellular Klebsiella pneumoniae 
In Vitro Virus Exposure (First Experiment) 
Alveolar Macrophages 
Exposure 
Time Virus Exposed 
* 2 hrs. 7.74 
9.60 
Mean + so 8.67 + 1.32 
4 hrs. 21.27 
Mean + so 
8 hrs. 
Mean + so 
12 hrs. 
Mean + SO 
19. 18 
20.23 + 1.48 
46.09 
39.42 
42.76 + 4.72 
50.87 
64.34 
57.60 + 9.52 




11.47 + 3.01 
38.27 
22.51 









1 .49 + 1.29 
36.57 
0.23 
18.40 + 25.7 
5.02 
0.0] 
2.52 + 3.54 
35.06 
29.28 




1.15 + 1.56 
2.59 
0.55 






1.33 + 0.96 
** Computer generated number; see text for explanation 
\TI 
N 
TABLE 10. Analysis of Variance for ~ Vitro 
Virus Exposure (First Experiment) 
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Source of Variation Probabil ity 
Between Treatments (virus vs. controls) 




Between Treatments X Locations 
Between Treatments X Times 
Between Locations X Times 









TABLE 11. Analysis of Variance by Group for In Vitro 
Virus Exposure (First Experiment) 
Groups Compared * Probab i 1 i ty 
VA2 - CA2 >.05 
VP2 - CP2 >.05 
VA+ - CA+ >.05 
VP+ - CP+ >.05 
VA2 - VP2 >.01 <.05 
CA2 - CP2 >.01 <.05 
VA+ '" VP+ >.05 
CA+ - CP+ >.01 <~05 
* V = vi rus exposed 
A = alveolar cells 
C = control 
P = per i tonea 1 ce 11 s 
2 = 2 hr sample 
+ = times over 2 hrs 
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TABLE 12 • Plate Counts of Intracellular Klebsiella £neumoniae 
. r,:! V i t ro Virus Exposu re (Second Expe r i men t ) 
Alveolar Macrophages Peritoneal Macrophages 
Exposure 
Time Virus Exposed Control Virus Exposed Control 
2 hr. 50 20 3 120 
3 200 0 0 
Mean + SD 26.5 + 33.2 110 + 127 1.5.:!: 2.12 60 + 84.8 
4 hr. 20 3 0 0 
3 963 70 0 
Mean + SD 11~5 + 12.0 483 .:!: 679 35 + 49.5 o + 0 
8 hr. 80 23 0 0 
0 170 0 
Mean + SD 40 .:!: 56.6 23 85 .:!: 120 o + 0 
12 hr. 0 56 0 10 
0 3 0 0 
Mean + SD o + 0 29.5 .:!: 37.5 o + 0 5 + 7.07 
V1 
V1 
TABLE 13. Analysis of Variance for lrr Vitro 
Virus Exposure (Second Experiment) 
Source of Variation 
Between Treatments (virus vs. controls) 
Between Locations (alveolar vs. peritoneal 
ce lls) 
Between Times 
Between Treatments X Locations 
Between Treatments X Times 
Between Locations X Times 










TABLE 1.4. Analysis of Variance by Group for 
In Vitro Virus Exposure (Second Experiment) 
Groups Compared * Probabil ity 
VA2 - CA2 >.05 
VP2 - CP2 >.05 
VA+ - CA+ >.05 
VP+ - CP+ >.05 
VA2 - VP2 >.05 
CA2 - CP2 >.05 
VA+ - VP+ >.05 
CA+ - CP+ >.05 
* V = virus exposed 
A = alveolar cells 
C = control 
P = per i tonea 1 cells 
2 = 2 hr sample 
+ = times over 2 hrs 
57 
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TABLE 15. Plate Counts of Intracellular 





Mean + SO 
4 hr, 
Mean + SO 
12 hr. 




















4,710 + 1,060 
12,200 







9,450 + 11,500 
TABLE 16. Analysis of Variance for 
In Vitro Virus Exposure (Third 
Experiment) 
Source of Variation Probabil ity 
Between Treatments (virus vs. controls) .392 
Between Times .055 
Between Treatments X Times .764 
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TABLE 17. Analysis of Variance by Group for 
In Vitro Virus Exposure (Third Experiment) 






VA2 ... CA2 
VA+ ... CA+ 
= virus exposed 
= alveolar ce 11 s 
= control 
= 2 hr sample 
= times over 2 hrs 































"" 1111 Peritoneal Cells, Virus Exposed .,....,....,...., ,,".,11,11 







1,11 ~/~/,...,. ~ 
.l ~t~t l '- ~~ 
fff ~,~ ~~ '" , 
ff ~,,, ~r '- ~ 
fff ~'" ~ '" ~ r 
ff I~'" ~ ~ '" , r l~/~f"" l ~ 
./ ~/~I ~~ .... , ~~ '-
,r.t I' ~ ~~ ........ ~ , "-
", ~I ~ ~ ~r ~ ~ , '" ",~" . ~ ~r ~ , "-,"~/~/~, ~~ ~~ I' "'", .&~.~ ~r ~ '" ~' ~ I r '" ~""''''''..,...,...,.''''''''''., '" 
Alveolar Cells, Control 
... ,~,~,.....:. 
Peritoneal Cells, Control 
1 2 3 4 5 6 7 8 9 10 11 12 
Time in hours 
Figure 4. Plate Counts of Intracellular Klebsiella pneumoniae In vitro 
Vi rus Exposure (Fi rst Experiment). Macrophages exposeato vi rus 0" 
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The counts differ due to variation in experimental 
conditions but they show the same trend. There was no 
significant difference (p >.05) in either phagocytosis 
or cytopepsis in either the alveolar or peritoneal 
macrophages. There was, however, a significant 
difference (p <.001) between the alveolar and the 
peritoneal macrophages in the first experiment (Figure 4 
and Tables 9 through 11), but not in the second (Figure 5 
and Tables 12 through l4). 
B. ~ Vivo Virus Exposure 
Figures 7 and 8 and Tables 18 through 23 show the 
results of two separate experiments in which the guinea 
pigs were exposed to an aerosol of virus 4 days prior 
to the time the macrophages were harvested. In both of 
these experiments the number of organisms phagocytized 
within the first 2 hours was considerably higher in 
the virus exposed macrophages than it was in the controls. 
However, due to the small sample size, the differences 
were not significant at the .05 probability level in the 
first experiment (Figure 7 and Tables 18 through 20). 
The second experiment (Figure 8 and Tables 21 through 23) 
was significant (p <.05). This app1 ied to peritoneal 
as well as to the alveolar macrophages. Intracellular 
multipl ication also took place much more rapidly in the 
virus exposed than in the control macrophages. In both 
TABLE 18. Plate Counts of Intracellular Klebsiella Eneumoniae 
lrr Vivo Virus Exposure (First Experiment) 
Alveolar Macrophages Peritoneal Macrophages 
Exposure 
Time Virus Exposed Control Virus Exposed Control 
.t. 
0.38 0.46 2 hr. 207" 0.20 
870 0.37 21 0.28 
Mean + so 539 + 469 0.285 + .120 10.7 + 14.6 0.37.:!: .127 
4 hr. 2800 0.08 361 0.10 
1042 0.10 2.4 0.03 
Mean + SO 1 92 1 .:!: 1 240 0.09 + .014 182 + 254 0.065 + .049 
8 hr. 1800 0.01 24 0.05 
3500 0.01 1385 0.03 
Mean + SO 2650 + 1200 0,,01 + 0 705 .:!: 962 0.04 + .014 
12 hr. 10400 0.05 4600 6.07 
9000 0.06 343 0.65 
Mean + SO 9700 + 990 0.055 + .007 2472 + 3010 3.36 + 3.83 
0' 
V1 
* All counts X 103 
TABLE 19. Analysis of Variance for 
In Vivo Virus Exposure (First Experiment) 








Treatments (v i rus vs. controls) 
Locations (alveolar vS o per i toneal 
ce 11 s ) 
Times 
Treatments X Locations 
Treatments X Times 
Locations X Times 









TABLE 20. Analysis of Variance by Group for 
~ Vivo Virus Exposure (First Experiment) 
Groups Compared"\' Probab i 1 i ty 
VA2 - CA2 >.05 
VP2 - CP2 >.05 
VA+ - CA+ >.01 <.05 
VP+ - CP+ >.05 
VA2 - VP2 >.05 
CA2 - CP2 >.05 
VA+ - VP+ >.05 
CA+ - CP+ >.05 
* V = vi rus exposed 
A = alveolar ce 11 s 
C = control 
P = peritoneal ce 11 s 
2 = 2 hr sample 
+ = times over 2 hrs 
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TABLE 21. Plate Counts of Intracellular 




Time Virus Exposed Control 




Mean + SO 5,800 + 2,350 840 + 1 ,51 0 
-
6 hr. > 106 1 ,080 
> 106 10,000 
> 106 550 
> 106 80,000 
Mean + SO > 106 + 0 22,900 ..:t 38,300 
10 hr. ~ > 106 35,000 
> 106 8,300 
> 106 28,300 
> 106 15,700 
Mean + SO > 106 + 0 21,800 + 12,000 
22 hr. All > 106 > 106 
tubes 





TABLE 22. Analysis of Variance for 
~ Vivo Virus Exposure (Second Experiment) 
Source of Variation 
Between Treatments (virus vs. controls) 
Between Times 






TABLE 23. Analysis of Variance by Group for 
lTI Vivo Virus Exposure (Second Experiment) 






VA2 - CA2 
VA+ - CA+ 
= virus exposed 
= alveolar ce 11 s 
= control 
= 2 hr sample 
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Figure 7- Plate Counts of Intracellular Klebsiella pneumoniae. In vivo Virus 
Exposure (First Experiment). Animals exposed to vlrus-r days 
prior to macrophage harvest. Macrophages allowed to attach 
overnight (approximately 18 hr.) prior to bacterial chejllenge 
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Figure 8. Plate Counts of Intracellular Klebsiella pneumoniae. In vivo 
Virus Exposure (Second Experiment). Animals exposed to-vIrUS 3 
days prior to macrophage harvest. Macrophages al lowed to attach 
overnight (approximately 18 hr.) prior to bacterial challenge 




experiments the alveolar macrophages which had been 
exposed to virus allowed intracellular multipl ication at 
a significantly greater rate (p <.05) than did the 
controls. There was less effect on the peritoneal 
macrophages (p >.05). 
Tables 19 and 22 show that there was a significant 
difference (p <.001) between virus exposed cells and 
controls. There was also a significant differen~e 
(p <.001) between alveolar and peritoneal macrophages. 
DISCUSSION 
The purpose of this research was to study the effect 
of viral infection on the phagocytic and cytopeptic 
capacities of the alveolar and peritoneal macrophages 
and to determine if possible the site at which inhibition 
takes place. This was accompl ished by comparing the 
number of ingested bacteria in macrophages ~ vitro at 
various time intervals after bacterial challenge. Prior 
virus exposure was done both in vivo and in vitro. The 
2 hour sample was considered the level of phagocytosis 
and the subsequent samples were considered increasing 
cytopepsis or intracellular mLllt}pJrc,ation. 
Attempts were made to correlate microscope counts 
of ingested bacteria with the plate counts but these 
efforts were without success. It was difficult to 
determine the number of ingested bacteria because the 
bacteria stained the same color and appeared to have the 
same morphology as many of the cytoplasmic granules of 
the macrophages. In addition, it was virtually impossible 
to tell if the bacteria were intracellular or extra-
ce 1 1 u 1 a r. 
The phagocyte donor animals used throughout this 
study were sacrificed by electrocution, with wall outlet 
current (115 v). By using electrocution, any effect on 
the peritoneal and alveolar phagocytes by anestetics 
75 
could be avoided. 
The bacterial organism that was used in this study 
was Klebsiella pneumoniae strain U-119. Klebsiella was 
used because it is found in the nose and mouth of 
healthy subjects and is frequently present as a secondary 
invader (after virus infection) in the lungs of patients 
with pneumonia. They cause approximately 3% of all 
acute bacterial pneumonias (11). These bacteria are also 
pathogenic for mice, guinea pigs and rabbits as well as 
man and have been used successfully in other experiments 
involving aspects of cellular immunity (29). 
Influenza virus has most frequently been the 
suspected predisposing agent in cl inical cases of bacterial 
pneumonia and most of the work on viral suppression of 
pulmonary defense mechanisms has been done with this virus. 
The Al/Ann Arbor/l/57 type of influenza virus was used 
because it was assumed that personnel 1 ikely to be 
accidently exposed to the virus would already have good 
immunity to it since the Al type was the most commonly 
encountered type between 1947 and 1957. 
Of the various methods for introducing bacteria or 
virus into the lungs, inhalation of an aerosol most 
closely simulates the natural mode of infection by 
droplet nuclei. Thus, aerosol exposure was chosen as the 
method of infecting the guinea pig macrophages. 
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It has been reported by Patterson and Youmans (50) 
that streptomycin inhibits intracellular mycobacterial 
prol iferation and that the effect was dependent upon the 
concentration of the antibiotic in the medium. Without 
the antibiotic in the medium, the bacill i multipl ied 
wit h i n II i mmu n e' ice lIs, and the rat e 0 f mu I tip 1 i cat i on 
was similar to the rate within normal cells. Also, the 
antibiotic exerted a greater inhibitory effect in concert 
with "immune 1l cells than when used with normal macrophages. 
They claimed that Iflmmunization of animals with living 
attenuated strains of facultative intracellular parasites 
to induce acquired cellular immunity results in the 
'activation' of cells of the reticuloendothel ial system 
(1, 10, 17,34,70). The use of irritants to stimulate 
peritoneal exudates also results in the 'activation' of 
macrophages (6 f 10). These iactivated ' cells are meta-
bol ically more active than normal cel Is (9), contain 
increased amounts of hydrolytic enzymes (6, 7, 34) and 
have increased physiological functions such as phago-
cytosis (9, 17) and pinocytosis (1).IM They suggest 
then that It ••• the I immune l macrophages in vitro may be more 
permeable to streptomycin and allow a more rapid uptake 
of the antibiotic or a greater antibiotic concentration 
within them, or both, thus bringing about the differential 
grow t h i n h i bit 0 rye f f e ct.'· (50) 
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Patterson and Youmans (50) doubt the hypothesis 
that cellular immunity resides in the ability of "immune
" 
macrophages to suppress the intracellular prol iferation 
of facultative intracellular microbes, but the present 
study lends support to the concept that streptomycin 
does not ordinarily affect intracellular organisms and 
that changes in the macrophage are responsible for in-
creased or decreased resistance to infection (65, 66, 67). 
1ft he vir u s ex p 0 sed 0 r II act i vat ed II ma crop ha g e sin the 
present studies ingested antibiotic in concentrations 
sufficient to be more inhibitory than the normal 
unexposed macrophages, then the rate of intracellular 
mUltipl ication should have been decreased. However, the 
rate was actually increased. 
Thorpe and Marcus have shown that except under 
abnormal circumstances, streptomycin was not found to 
enter the cells or to affect intracellular organisms. 
liThe penetration of streptomycin into actively metabol izing 
phagocytic cells in concentrations sufficient to be 
inhibitory to the organisms was often observed when any 
of the following or combinations of these factors were 
apparent: (1) thermal shock to the phagocytes, (2) 
uncontrolled pH of the menstrum, (3) presence of par-
ticulate material (india ink, dead organisms, and 
perhaps macromolecules), (4) physical shock, (5) 
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tryps i n i zat ion, (6) certa i n chem; ca 1 s (hepar in, 
de t e r ge n t s, d i ch r oma t e ; 0 n s, a c; d s), and (7) i mp r op e r 1 y 
cleaned glassware. II (65) Experimental design avoided 
these conditions and the data show that the intracellular 
organisms mUltiply rapidly within the cells of the 
lJactivatedlJ macrophages faster than in the unexposed 
cell s. 
If the glycogen that was used to stimulate the 
peritoneal macrophages stimulated the production of 
"ac tivated" macrophages, it is not obvious from these 
exp e rime n t s • I n ever y ex per i me n t the per ito n ea 1 
macrophages ingested about the same number or fewer 
bacteria than did the alveolar macrophages. This was 
true for both the control macrophages and the virus 
exposed macrophages. 
Many workers have studied the reduction of viable 
bacteria in the lung and have used the terms clearance 
or el imination; others have used the same terms when 
referring to the mechanical removal of bacteria which 
mayor may not be viable. This use of double meanings 
for the same terms can cause confus i on. In th is paper 
the terms clearance, cleansing, or el imination are used 
when referring to the mechanical removal of bacteria and 
processes which result in the reduction of viable bacteria 
are referred to as bactericidal mechanisms. 
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There also seems to be some confusion concerning 
the meaning of the term phagocytosis. Frequently no 
distinction is made between ingestion and digestion or 
the two processes are treated as one. In this paper 
the term phagocytosis refers only to ingestion; the term 
cytopepsis is used in reference to intracellular kill ing 
and digestion. 
As frequently happens this work has raised more 
questions than it has answered. It was shown that in 
vivo virus infection increased the ingestion of bacteria 
by macrophages with decreased cytopepsis, but this was 
only determined for the fourth day following virus 
exposure. It would be of interest to determine how soon 
after viral challenge the phenomenon of increased 
ingestion and decreased cytopepsis appears and how long 
it lasts. It would also be interesting to see if the 
two effects are correlated. 
It has been proposed that the virus infection could 
stimulate the production by the host of a factor which 
actually causes interference with macrophage activity. 
For example, the virus infection might stimulate the 
production of corticosteroids which cause the observed 
inhibition. If so, that would explain why there was no 
inhibition of macrophage function with in vitro virus 
exposure. 
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It has been shown by others that immunization 
against either the virus or the bacteria will protect 
the animal (1,2, ,2:9) and that immunization increases the 
capaci ty of macrophages to handl e bacter i a (8·, 45). It 
will be important to see how immunization against the 
virus, the bacteria, or with nonspecific material will 
affect the abil ity of the macrophage to phagocytize and 
digest bacteria after virus exposure. The effect of 
killed virus on the macrophage after these various 
treatments might also prove informative. Although not 
apparent from this study, the possibi1 ity also exists 
that macrophages receiving the various treatments might 
exhibit morphological differenc5as well as enzymatic 
or metabol ic differences. 
The ro1 e of interferon : has:. not been considered 
in these studies. The correlation between interferon 
production and suppression of antibacterial capacity of 
the macrophage should be explored. 
It is known that delayed hypersensitivity is some-
times temporarily depressed during certain viral ill-
nesses' especially measles and influenza (68). It would 
be of value to investigate the role of virus concerning 
the mechanism of involvement in the depression of delayed 
hypersensitivity-
Separation of the monocytes, lymphocytes, and PMN' S 
8·1 
might be attempted to see if the same results would be 
observed. If possible, interaction between different 
cell types needs to be investigated. 
Still another possibil ity for further investigation 
would be to ~hange the route of exposure to the virus. 
Would the results be the same if the animals were challenged 
by the intraperitoneal or intravenous routes? 
The apparent decreased abil ity of the virus exposed 
macrophages to inhibit intracellular multipl ication 
may be due to the increased mUltipl icity of infection 
by the bacteria. The virus exposed macrophage may be 
less able to digest the ingested bacteria simply because 
these cells contain more bacteria as a result of 
"activation
" 
and increased ingestion. Lower challenge 
doses of bacteria should be investigated. 
Shope (61) may have been close' to real ity when he 
proposed that viruses convert pulmonary tissues to a 
favorable bacterial culture medium. Viruses apparently 
depress the digestive capacity of the alveolar macrophage 
so that rapid intracellular multipl ication can take place. 
This could also be the process involved in the viral 
potentiation of pulmonary tuberculous infection reported 
by Volkert, Pierce, Horsfall, and Dubas (69) who found 
that virus acts to make conditions favorable for bacterial 
growth and for development of tuberculous lesions. 
8~ 
The increased speed of distribution of bacteria through. 
out the lung of animals previously infected by virus, 
as reported by McCordock and Muckenfuss (47), could be 
due to the fact that the bacteria are protected from 
humoral factors and transported throughout the host in 
the virus exposed macrophage. 
The apparently altered virulence of bacteria in virus 
exposed animals may best be explained not by any change 
in the bacteria but by the decreased abil ity of the 
macrophage to digest the bacteria. The fate of bacteria 
with increased virulence phagocytized by a normal macro-
phage would be similar to the fate of unaltered 
organisms phagocytized by a macrophage with decreased 
cytopeptic capacity. Thus, it would appear, as Francis 
and Torregrose (20) proposed, that the virus had altered 
the virulence of the bacteria. 
Harford and Haml in (32) and others (22, 33) 
concluded that the effect of the virus was due to the viral 
lesion or the edema fluid because they could not find 
interference with other mechanisms. These workers did 
not, however, exclude effects on the macrophage. Harford, 
Leidler, and Hara (33) tried to explain the viral.bacterial 
interaction on the basis of some effect produced by the 
virus lesion, but by so doing they were unable to explain 
how viral suppression of antibacterial defense was produced 
in those cases where no lesions were produced. The 
method suggested in this thesis does not require the 
production of a lesion. 
Green and Kass (27) suggested that bactericidal 
capacity of the lung depended on the phagocytic activity 
of pulmonary macrophages and that the inhibiting effect 
of agents could be attributed to impairment of the 
bactericidal action of macrophages by inhibition of 
either phagocytosis or cytopepsis. This suggestion is 
supported by the work reported in this thesis which 
points to depressed cytopepsis as the critical failure 
which occurs in infection involving ~'~rus and bacteria. 
It has been shown in this thesis that the lowered 
resistance to bacterial pneumonia which follows influenza 
virus infection can be at least partially attributed to 
interference with the activity of pulmonary macrophages. 
This lowered resistance seems to be due to viral inter-
ference with cytopepsis. It has also been shown that 
in vitro virus exposure does not produce this suppression 
suggesting that the macrophages of the virus exposed 
animals may be different populations than those of normal 
animals or that other host factors may be required to 
react with the cells to lessen their effectiveness. 
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